Kodiak Sciences Inc. Kodiak Sciences Inc.

Kodiak Sciences Inc.

KOD

Kedudukan dalam Saham #3149
Kodiak Sciences Inc. is a biopharmaceutical firm currently in the clinical... Kodiak Sciences Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering, advancing, and bringing to market treatments for various conditions affecting the retina. Their primary drug candidate, KSI-301, is an anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer. This compound is currently undergoing Phase IIb/III clinical trials, targeting illnesses such as wet age-related macular degeneration (AMD), diabetic macular edema, previously untreated macular edema resulting from retinal vein occlusion, and non-proliferative diabetic retinopathy. In its earlier, preclinical development pipeline, the company is also working on KSI-501, a bispecific conjugate designed for retinal conditions involving inflammation, and KSI-601, a triplet inhibitor aimed at addressing dry AMD. Established in 2009, this Palo Alto, California-based company operated under the name Oligasis, LLC before rebranding as Kodiak Sciences Inc. in September 2015.
Harga Saham
$91.35
Disegerakkan terakhir: 2026-10-19
Modal Pasaran
$5.74B
Perubahan (1 hari)
6.53%
Perubahan (1 tahun)
416.10%
Negara
US
Perdagangan Kodiak Sciences Inc. (KOD)

Kategori

Healthcare
Sejarah pecahan saham untuk Kodiak Sciences Inc. (KOD)
Saham Kodiak Sciences Inc. (simbol: KOD) telah mengalami sejumlah 1 pecahan saham.
Pecahan saham terkini berlaku pada Feb 23, 2022.
Satu saham KOD yang dibeli sebelum Feb 23, 2022 kini bersamaan dengan 5 saham KOD.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
2022-02-23 5:1 x5 x5
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL